Literature DB >> 15301465

A cost-effective particle agglutination assay to detect viral antibodies in dried blood spots--a simple solution to HIV and HCV screening.

J J Jourbert1, J B Dewar, J Weinberg, M De Beer, J S Parker, A D Steele.   

Abstract

OBJECTIVES: To conduct a serological survey of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) in Gabon and Ga-Rankuwa, South Africa. A secondary objective was to test a novel, simple, inexpensive agglutination assay for anti-HIV IgG and anti-HCV IgG from blood samples stored as spots dried onto filter paper.
DESIGN: Blood from heel pricks was dried onto filter paper and stored. Blood was eluted from the spots and serum antibody was then assayed using a modified agglutination assay--blood was added to gelatin agglutination beads that had been sensitised with viral antigen. A positive result showed as an agglutination pattern while a negative result appeared as a tight bead. SUBJECT: This was a hospital-based study involving 271 neonates at Ga-Rankuwa Hospital, South Africa, and 856 patients ranging in age from three months to over 50 years who attended clinics in Gabon.
RESULTS: Seroprevalence to HIV was determined in Ga-Rankuwa to be just under 14% (13.8%). Antibodies to HCV were not detected. In Gabon, the prevalence to HIV was just under 1% (0.82%) with a relatively high incidence of HCV, nearing 4% (3.79%).
CONCLUSION: The sensitivity of the agglutination assay compared favourably to enzyme immune assay (EIA) with respect to sensitivity, simplicity and cost. This assay may be useful in sero-epidemilogical assays in developing countries.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15301465

Source DB:  PubMed          Journal:  Cent Afr J Med        ISSN: 0008-9176


  3 in total

1.  Use of dried spots of whole blood, plasma, and mother's milk collected on filter paper for measurement of human immunodeficiency virus type 1 burden.

Authors:  Workenesh Ayele; Rob Schuurman; Tsehaynesh Messele; Wendelien Dorigo-Zetsma; Yohannes Mengistu; Jaap Goudsmit; William A Paxton; Michel P de Baar; Georgios Pollakis
Journal:  J Clin Microbiol       Date:  2007-01-24       Impact factor: 5.948

Review 2.  Current testing strategies for hepatitis C virus infection in blood donors and the way forward.

Authors:  Neelam Marwaha; Suchet Sachdev
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

3.  Hepatitis C virus seroprevalence in pregnant women delivering live-born infants in North Thames, England in 2012.

Authors:  M Cortina-Borja; D Williams; C S Peckham; H Bailey; C Thorne
Journal:  Epidemiol Infect       Date:  2015-07-16       Impact factor: 2.451

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.